“Don't keep me waiting”: estimating the impact of reduced vein-to-vein time on lifetime US 3L+ LBCL patient outcomes

Vadgama, S. orcid.org/0000-0002-9138-8471, Pasquini, M.C. orcid.org/0000-0003-1579-2293, Maziarz, R.T. orcid.org/0000-0002-8184-7099 et al. (7 more authors) (2024) “Don't keep me waiting”: estimating the impact of reduced vein-to-vein time on lifetime US 3L+ LBCL patient outcomes. Blood Advances, 8 (13). pp. 3519-3527. ISSN 2473-9529

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2024 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution - https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode

Keywords: Humans; Immunotherapy, Adoptive; Lymphoma, Large B-Cell, Diffuse; Quality-Adjusted Life Years; Treatment Outcome; United States; Time Factors; Cost-Benefit Analysis
Dates:
  • Published: 9 July 2024
  • Published (online): 28 June 2024
  • Accepted: 18 April 2024
  • Submitted: 7 February 2024
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > ScHARR - Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 31 Jan 2025 11:21
Last Modified: 31 Jan 2025 11:21
Status: Published
Publisher: American Society of Hematology
Refereed: Yes
Identification Number: 10.1182/bloodadvances.2023012240
Related URLs:
Sustainable Development Goals:
  • Sustainable Development Goals: Goal 3: Good Health and Well-Being
Open Archives Initiative ID (OAI ID):

Export

Statistics